Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Fascì Spurio

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Scandinavian Journal of Gastroenterology|January 6, 2016
A new form of chronic inflammatory bowel disease associated with chronic liver diseaseFederica Fascì-Spurio, Polychronis Pavlidis, Ingvar Bjarnason
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 13, 2017
The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD surveyFederica Fascì-Spurio, Gianmichele Meucci, Claudio Papi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 17, 2011
Do not disturb the sleeping wormFederica Fascì Spurio, Annalisa Aratari, Giuseppe Emilio Bazuro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 13, 2020
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concernsStefano Festa, Annalisa Aratari, Fabiola De Biasio, et al.
Expert Review of Gastroenterology & Hepatology|June 3, 2014
Low bioavailability steroids in inflammatory bowel disease: an old chestnut or a whole new ballgame?Simone Saibeni, Gianmichele Meucci, Claudio Papi, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2012
Early treatment in Crohn's disease: do we have enough evidence to reverse the therapeutic pyramid?Federica Fascì Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 11, 2013
Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factorsClaudio Papi, Federica Fascì-Spurio, Francesca Rogai, et al.
Expert Review of Gastroenterology & Hepatology|November 3, 2016
The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technologyCristina Bezzio, Federica Fascì-Spurio, Chiara Viganò, et al.
Current Clinical Pharmacology|March 22, 2012
Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's diseaseFederica Fascì Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Recenti Progressi in Medicina|June 11, 2013
[Prevention of post-operative recurrence in Crohn's disease: a critical review of randomized controlled trials and meta-analyses of different therapeutic strategies]Giovanna Margagnoni, Valeria Clemente, Annalisa Aratari, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Scandinavian Journal of Gastroenterology|January 6, 2016
A new form of chronic inflammatory bowel disease associated with chronic liver diseaseFederica Fascì-Spurio, Polychronis Pavlidis, Ingvar Bjarnason
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 13, 2017
The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD surveyFederica Fascì-Spurio, Gianmichele Meucci, Claudio Papi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 17, 2011
Do not disturb the sleeping wormFederica Fascì Spurio, Annalisa Aratari, Giuseppe Emilio Bazuro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 13, 2020
Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concernsStefano Festa, Annalisa Aratari, Fabiola De Biasio, et al.
Expert Review of Gastroenterology & Hepatology|June 3, 2014
Low bioavailability steroids in inflammatory bowel disease: an old chestnut or a whole new ballgame?Simone Saibeni, Gianmichele Meucci, Claudio Papi, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2012
Early treatment in Crohn's disease: do we have enough evidence to reverse the therapeutic pyramid?Federica Fascì Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 11, 2013
Mucosal healing in inflammatory bowel disease: treatment efficacy and predictive factorsClaudio Papi, Federica Fascì-Spurio, Francesca Rogai, et al.
Expert Review of Gastroenterology & Hepatology|November 3, 2016
The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technologyCristina Bezzio, Federica Fascì-Spurio, Chiara Viganò, et al.
Current Clinical Pharmacology|March 22, 2012
Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's diseaseFederica Fascì Spurio, Annalisa Aratari, Giovanna Margagnoni, et al.
Recenti Progressi in Medicina|June 11, 2013
[Prevention of post-operative recurrence in Crohn's disease: a critical review of randomized controlled trials and meta-analyses of different therapeutic strategies]Giovanna Margagnoni, Valeria Clemente, Annalisa Aratari, et al.
Pageof 2